Overview

Dasotraline Pediatric Extension Study

Status:
Completed
Trial end date:
2017-02-02
Target enrollment:
Participant gender:
Summary
This is an open label 26 week extension study for subjects who completed SEP360-202.
Phase:
Phase 3
Details
Lead Sponsor:
Sunovion